# The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

> **NCT04733443** · NA · UNKNOWN · sponsor: **JW Medical Systems Ltd** · enrollment: 310 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Biolimus
- **DEVICE:** SeQuent® Please Neo

## Key facts

- **NCT ID:** NCT04733443
- **Lead sponsor:** JW Medical Systems Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-17
- **Primary completion:** 2023-01-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04733443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04733443, "The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04733443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*